| Year |
Citation |
Score |
| 2021 |
Soliman E, Bhalla S, Elhassanny AEM, Malur A, Ogburn D, Leffler N, Malur AG, Thomassen MJ. Myeloid ABCG1 Deficiency Enhances Apoptosis and Initiates Efferocytosis in Bronchoalveolar Lavage Cells of Murine Multi-Walled Carbon Nanotube-Induced Granuloma Model. International Journal of Molecular Sciences. 23. PMID 35008476 DOI: 10.3390/ijms23010047 |
0.314 |
|
| 2021 |
Barna BP, Judson MA, Thomassen MJ. Inflammatory Pathways in Sarcoidosis. Advances in Experimental Medicine and Biology. 1304: 39-52. PMID 34019262 DOI: 10.1007/978-3-030-68748-9_3 |
0.31 |
|
| 2021 |
Barna BP, Malur A, Thomassen MJ. Studies in a Murine Granuloma Model of Instilled Carbon Nanotubes: Relevance to Sarcoidosis. International Journal of Molecular Sciences. 22. PMID 33918196 DOI: 10.3390/ijms22073705 |
0.34 |
|
| 2020 |
Mohan A, Neequaye N, Malur A, Soliman E, McPeek M, Leffler N, Ogburn D, Tokarz DA, Knudson W, Gharib SA, Schnapp LM, Barna BP, Thomassen MJ. Matrix Metalloproteinase-12 Is Required for Granuloma Progression. Frontiers in Immunology. 11: 553949. PMID 33072094 DOI: 10.3389/Fimmu.2020.553949 |
0.304 |
|
| 2020 |
Soliman E, Elhassanny AEM, Malur A, McPeek M, Bell A, Leffler N, Van Dross R, Jones JL, Malur AG, Thomassen MJ. Impaired mitochondrial function of alveolar macrophages in carbon nanotube-induced chronic pulmonary granulomatous disease. Toxicology. 445: 152598. PMID 32976959 DOI: 10.1016/j.tox.2020.152598 |
0.349 |
|
| 2020 |
Madenspacher JH, Morrell ED, Gowdy KM, McDonald JG, Thompson BM, Muse GW, Martinez J, Thomas SY, Mikacenic C, Nick JA, Abraham E, Garantziotis S, Stapleton RD, Meacham JM, Thomassen MJ, et al. Cholesterol-25-hydroxylase promotes efferocytosis and resolution of lung inflammation. Jci Insight. PMID 32343675 DOI: 10.1172/Jci.Insight.137189 |
0.489 |
|
| 2019 |
McPeek M, Malur A, Tokarz DA, Lertpiriyapong K, Gowdy KM, Murray G, Wingard CJ, Fessler MB, Barna BP, Thomassen MJ. Alveolar Macrophage ABCG1 Deficiency Promotes Pulmonary Granulomatous Inflammation. American Journal of Respiratory Cell and Molecular Biology. PMID 30848658 DOI: 10.1165/Rcmb.2018-0365Oc |
0.545 |
|
| 2019 |
Malur A, Mohan A, Barrington RA, Leffler N, Malur A, Muller-Borer B, Murray G, Kew K, Zhou C, Russell J, Jones JL, Wingard CJ, Barna BP, Thomassen MJ. PPARγ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model. American Journal of Respiratory Cell and Molecular Biology. PMID 30741559 DOI: 10.1165/Rcmb.2018-0346Oc |
0.494 |
|
| 2018 |
McPeek M, Malur A, Tokarz DA, Murray G, Barna BP, Thomassen MJ. PPAR-gamma pathways attenuate pulmonary granuloma formation in a carbon nanotube induced murine model of sarcoidosis. Biochemical and Biophysical Research Communications. PMID 29908181 DOI: 10.1016/J.Bbrc.2018.06.061 |
0.544 |
|
| 2017 |
Mohan A, Malur A, McPeek M, Barna BP, Schnapp LM, Thomassen MJ, Gharib SA. Transcriptional Survey of Alveolar Macrophages in a Murine Model of Chronic Granulomatous Inflammation Reveals Common Themes with Human Sarcoidosis. American Journal of Physiology. Lung Cellular and Molecular Physiology. ajplung.00289.2017. PMID 29212802 DOI: 10.1152/Ajplung.00289.2017 |
0.411 |
|
| 2017 |
Hunt AN, Malur A, Monfort T, Lagoudakis P, Mahajan S, Postle AD, Thomassen MJ. Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis. American Journal of Respiratory Cell and Molecular Biology. PMID 28489415 DOI: 10.1165/Rcmb.2016-0242Oc |
0.371 |
|
| 2016 |
Wang Z, DiDonato JA, Buffa JA, Comhair SA, Aronica MA, Dweik R, Lee NA, Lee JJ, Thomassen MJ, Kavuru M, Erzurum SC, Hazen SL. Eosinophil Peroxidase Catalyzed Protein Carbamylation Participates in Asthma. The Journal of Biological Chemistry. PMID 27587397 DOI: 10.1074/Jbc.M116.750034 |
0.312 |
|
| 2016 |
Gharib SA, Malur A, Huizar I, Barna BP, Kavuru MS, Schnapp LM, Thomassen MJ. Sarcoidosis activates diverse transcriptional programs in bronchoalveolar lavage cells Respiratory Research. 17: 93-93. PMID 27460362 DOI: 10.1186/S12931-016-0411-Y |
0.355 |
|
| 2015 |
Malur A, Barna BP, Patel J, McPeek M, Wingard CJ, Dobbs L, Thomassen MJ. Exposure to a Mycobacterial Antigen, ESAT-6, Exacerbates Granulomatous and Fibrotic Changes in a Multiwall Carbon Nanotube Model of Chronic Pulmonary Disease. Journal of Nanomedicine & Nanotechnology. 6. PMID 27019768 DOI: 10.4172/2157-7439.1000340 |
0.429 |
|
| 2015 |
Barna BP, McPeek M, Malur A, Fessler MB, Wingard CJ, Dobbs L, Verbanac KM, Bowling M, Judson MA, Thomassen MJ. Elevated miRNA-33 in Sarcoidosis and a Carbon Nanotube Model of Chronic Granulomatous Disease. American Journal of Respiratory Cell and Molecular Biology. PMID 26641802 DOI: 10.1165/Rcmb.2015-0332Oc |
0.36 |
|
| 2014 |
Thomassen MJ, Kavuru MS. Lung disease: Treatment by cell transplant Nature. 514: 438-440. PMID 25274303 DOI: 10.1038/Nature13758 |
0.472 |
|
| 2013 |
Barna BP, Huizar I, Malur A, McPeek M, Marshall I, Jacob M, Dobbs L, Kavuru MS, Thomassen MJ. Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation International Journal of Molecular Sciences. 14: 23858-23871. PMID 24322444 DOI: 10.3390/Ijms141223858 |
0.486 |
|
| 2013 |
Dalrymple H, Barna BP, Malur A, Malur AG, Kavuru MS, Thomassen MJ. Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes Bmc Immunology. 14: 41-41. PMID 24044676 DOI: 10.1186/1471-2172-14-41 |
0.761 |
|
| 2013 |
Huizar I, Malur A, Patel J, McPeek M, Dobbs L, Wingard CJ, Barna BP, Thomassen MJ. The role of PPARγ in carbon nanotube-elicited granulomatous lung inflammation Respiratory Research. 14: 7-7. PMID 23343389 DOI: 10.1186/1465-9921-14-7 |
0.518 |
|
| 2012 |
Barna BP, Culver DA, Kanchwala A, Singh RJ, Huizar I, Abraham S, Malur A, Marshall I, Kavuru MS, Thomassen MJ. Alveolar macrophage cathelicidin deficiency in severe sarcoidosis Journal of Innate Immunity. 4: 569-578. PMID 22759465 DOI: 10.1159/000339149 |
0.494 |
|
| 2012 |
Malur A, Kavuru MS, Marshall I, Barna BP, Huizar I, Karnekar R, Thomassen MJ. Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis Respiratory Research. 13. PMID 22697800 DOI: 10.1186/1465-9921-13-46 |
0.504 |
|
| 2012 |
Sharma S, Malur A, Marshall I, Huizar I, Barna BP, Pories W, Dohm L, Kavuru MS, Thomassen MJ. Alveolar macrophage activation in obese patients with obstructive sleep apnea Surgery. 151: 107-112. PMID 21982524 DOI: 10.1016/J.Surg.2011.06.035 |
0.416 |
|
| 2011 |
Malur A, Huizar I, Wells G, Barna BP, Malur AG, Thomassen MJ. Lentivirus-ABCG1 instillation reduces lipid accumulation and improves lung compliance in GM-CSF knock-out mice. Biochemical and Biophysical Research Communications. 415: 288-293. PMID 22033401 DOI: 10.1016/J.Bbrc.2011.10.043 |
0.534 |
|
| 2011 |
Huizar I, Malur A, Midgette YA, Kukoly C, Chen P, Ke PC, Podila R, Rao AM, Wingard CJ, Dobbs L, Barna BP, Kavuru MS, Thomassen MJ. Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes. American Journal of Respiratory Cell and Molecular Biology. 45: 858-66. PMID 21398620 DOI: 10.1165/Rcmb.2010-0401Oc |
0.436 |
|
| 2011 |
Malur A, Baker AD, McCoy AJ, Wells G, Barna BP, Kavuru MS, Malur AG, Thomassen MJ. Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice. American Journal of Physiology. Lung Cellular and Molecular Physiology. 300: L73-80. PMID 21036914 DOI: 10.1152/Ajplung.00128.2010 |
0.559 |
|
| 2010 |
Baker AD, Malur A, Barna BP, Kavuru MS, Malur AG, Thomassen MJ. PPARgamma regulates the expression of cholesterol metabolism genes in alveolar macrophages. Biochemical and Biophysical Research Communications. 393: 682-7. PMID 20170635 DOI: 10.1016/J.Bbrc.2010.02.056 |
0.415 |
|
| 2010 |
Baker AD, Malur A, Barna BP, Ghosh S, Kavuru MS, Malur AG, Thomassen MJ. Targeted PPAR{gamma} deficiency in alveolar macrophages disrupts surfactant catabolism. Journal of Lipid Research. 51: 1325-31. PMID 20064973 DOI: 10.1194/Jlr.M001651 |
0.525 |
|
| 2009 |
Malur A, Mccoy AJ, Arce S, Barna BP, Kavuru MS, Malur AG, Thomassen MJ. Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response. Journal of Immunology (Baltimore, Md. : 1950). 182: 5816-22. PMID 19380830 DOI: 10.4049/Jimmunol.0803504 |
0.511 |
|
| 2009 |
Barna BP, Malur A, Dalrymple H, Karnekar R, Culver DA, Abraham S, Singh RJ, Brescia D, Kavuru MS, Thomassen MJ. A novel 1,25-dihydroxyvitamin D - Activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP) Autoimmunity. 42: 56-62. PMID 18803071 DOI: 10.1080/08916930802316277 |
0.731 |
|
| 2008 |
Bonfield TL, Thomassen MJ, Farver CF, Abraham S, Koloze MT, Zhang X, Mosser DM, Culver DA. Peroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factor. Journal of Immunology (Baltimore, Md. : 1950). 181: 235-42. PMID 18566389 DOI: 10.4049/Jimmunol.181.1.235 |
0.512 |
|
| 2008 |
Dalrymple H, Malur A, Gagnon G, Marshall I, Kavuru M, Barna B, Thomassen M. Rituximab Depletes B-Lymphocytes and Improves Symptoms in Pulmonary Alveolar Proteinosis The Journal of Allergy and Clinical Immunology. 121. DOI: 10.1016/J.Jaci.2007.12.890 |
0.707 |
|
| 2007 |
Thomassen MJ, Barna BP, Malur AG, Bonfield TL, Farver CF, Malur A, Dalrymple H, Kavuru MS, Febbraio M. ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. Journal of Lipid Research. 48: 2762-8. PMID 17848583 DOI: 10.1194/Jlr.P700022-Jlr200 |
0.767 |
|
| 2006 |
Venkateshiah SB, Yan TD, Bonfield TL, Thomassen MJ, Meziane M, Czich C, Kavuru MS. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest. 130: 227-37. PMID 16840407 DOI: 10.1378/Chest.130.1.227 |
0.465 |
|
| 2006 |
Li J, Sai T, Berger M, Chao Q, Davidson D, Deshmukh G, Drozdowski B, Ebel W, Harley S, Henry M, Jacob S, Kline B, Lazo E, Rotella F, Routhier E, ... ... Thomassen MJ, et al. Human antibodies for immunotherapy development generated via a human B cell hybridoma technology. Proceedings of the National Academy of Sciences of the United States of America. 103: 3557-62. PMID 16505368 DOI: 10.1073/Pnas.0511285103 |
0.34 |
|
| 2006 |
Bonfield TL, Barna BP, John N, Malur A, Culver DA, Kavuru MS, Thomassen MJ. Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF Journal of Autoimmunity. 26: 37-41. PMID 16337108 DOI: 10.1016/J.Jaut.2005.10.004 |
0.505 |
|
| 2006 |
Bonfield TL, Swaisgood CM, Barna BP, Farver CF, Kavuru MS, Thomassen MJ. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor. Journal of Leukocyte Biology. 79: 133-9. PMID 16275889 DOI: 10.1189/Jlb.0805447 |
0.462 |
|
| 2006 |
Thomassen MJ, Bonfield TL, Barna BP, John N, Kavuru MS. Activin A Deficiency: Association with Autoimmune Lung Disease The Journal of Allergy and Clinical Immunology. 117. DOI: 10.1016/J.Jaci.2005.12.082 |
0.365 |
|
| 2005 |
Kobayashi M, Thomassen MJ, Rambasek T, Bonfield TL, Raychaudhuri B, Malur A, Winkler AR, Barna BP, Goldman SJ, Kavuru MS. An inverse relationship between peroxisome proliferator-activated receptor gamma and allergic airway inflammation in an allergen challenge model. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 95: 468-73. PMID 16312170 DOI: 10.1016/S1081-1206(10)61173-8 |
0.428 |
|
| 2005 |
Bonfield TL, John N, Barna BP, Kavuru MS, Thomassen MJ, Yen-Lieberman B. Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test. Clinical and Diagnostic Laboratory Immunology. 12: 821-4. PMID 16002629 DOI: 10.1128/Cdli.12.7.821-824.2005 |
0.437 |
|
| 2005 |
Wu J, Kobayashi M, Sousa EA, Liu W, Cai J, Goldman SJ, Dorner AJ, Projan SJ, Kavuru MS, Qiu Y, Thomassen MJ. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Molecular & Cellular Proteomics : McP. 4: 1251-64. PMID 15951573 DOI: 10.1074/Mcp.M500041-Mcp200 |
0.301 |
|
| 2005 |
Bonfield TL, John N, Malur A, Barna BP, Culver DA, Kavuru MS, Thomassen MJ. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression Clinical Immunology. 114: 79-85. PMID 15596412 DOI: 10.1016/J.Clim.2004.09.004 |
0.572 |
|
| 2004 |
Meaney S, Bonfield TL, Hansson M, Babiker A, Kavuru MS, Thomassen MJ. Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: increased levels in patients with pulmonary alveolar proteinosis. Journal of Lipid Research. 45: 2354-60. PMID 15466366 DOI: 10.1194/Jlr.M400302-Jlr200 |
0.4 |
|
| 2004 |
Venkateshiah SB, Thomassen MJ, Kavuru MS. Pulmonary alveolar proteinosis. Clinical manifestations and optimal treatment strategies. Treatments in Respiratory Medicine. 3: 217-227. PMID 15350160 DOI: 10.2165/00151829-200403040-00002 |
0.521 |
|
| 2004 |
Culver DA, Barna BP, Raychaudhuri B, Bonfield TL, Abraham S, Malur A, Farver CF, Kavuru MS, Thomassen MJ. Peroxisome Proliferator-Activated Receptor γ Activity Is Deficient in Alveolar Macrophages in Pulmonary Sarcoidosis American Journal of Respiratory Cell and Molecular Biology. 30: 1-5. PMID 14512375 DOI: 10.1165/Rcmb.2003-0304Rc |
0.468 |
|
| 2004 |
Raychaudhuri B, Abraham S, Bonfield TL, Malur A, Deb A, DiDonato JA, Kavuru MS, Thomassen MJ. Surfactant blocks lipopolysaccharide signaling by inhibiting both mitogen-activated protein and IkappaB kinases in human alveolar macrophages. American Journal of Respiratory Cell and Molecular Biology. 30: 228-32. PMID 12920056 DOI: 10.1165/Rcmb.2003-0263Oc |
0.417 |
|
| 2004 |
Venkateshiah SB, Yan T, Bonfield T, Thomassen MJ, Czich C, Kavuru MS. Recombinant Human Granulocyte Macrophage Colony Stimulating Factor (rhGM-CSF) therapy in Pulmonary Alveolar Proteinosis (PAP): An open label phase II clinical trial Chest. 126. DOI: 10.1378/Chest.126.4_Meetingabstracts.755S-A |
0.428 |
|
| 2004 |
Rambasek TE, Follettie MT, Wang IW, Wei S, Cai J, Bonfield TL, Malur A, Barna BP, Isabella T, Goldman SL, Kavuru MS, Kobayashi M, Thomassen M. PPAR-γ activity is deficient in alveolar macrophages of allergic asthmatics The Journal of Allergy and Clinical Immunology. 113. DOI: 10.1016/J.Jaci.2004.01.126 |
0.4 |
|
| 2003 |
Thomassen MJ, Raychaudhuri B, Bonfield TL, Malur A, Abraham S, Barna BP, Kavuru MS. Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis. Autoimmunity. 36: 285-90. PMID 14567558 DOI: 10.1080/0891693031000152688 |
0.403 |
|
| 2003 |
Bonfield TL, Raychaudhuri B, Malur A, Abraham S, Trapnell BC, Kavuru MS, Thomassen MJ. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. American Journal of Physiology. Lung Cellular and Molecular Physiology. 285: L1132-6. PMID 12896880 DOI: 10.1152/Ajplung.00216.2003 |
0.555 |
|
| 2003 |
Bonfield TL, Farver CF, Barna BP, Malur A, Abraham S, Raychaudhuri B, Kavuru MS, Thomassen MJ. Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. American Journal of Respiratory Cell and Molecular Biology. 29: 677-82. PMID 12805087 DOI: 10.1165/Rcmb.2003-0148Oc |
0.542 |
|
| 2003 |
Kavuru MS, Bonfield TL, Thomassen MJ. Plasmapheresis, GM-CSF, and alveolar proteinosis. American Journal of Respiratory and Critical Care Medicine. 167: 1036; author reply 1. PMID 12663343 DOI: 10.1164/Ajrccm.167.7.950 |
0.419 |
|
| 2002 |
Mazzone PJ, Thomassen MJ, Kavuru MS. Pulmonary Alveolar Proteinosis: recent advances. Seminars in Respiratory and Critical Care Medicine. 23: 115-126. PMID 16088604 DOI: 10.1055/S-2002-25375 |
0.501 |
|
| 2002 |
Bonfield TL, Kavuru MS, Thomassen MJ. Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clinical Immunology (Orlando, Fla.). 105: 342-50. PMID 12498816 DOI: 10.1006/Clim.2002.5301 |
0.441 |
|
| 2002 |
Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. American Journal of Respiratory Cell and Molecular Biology. 27: 481-6. PMID 12356582 DOI: 10.1165/Rcmb.2002-0023Oc |
0.556 |
|
| 2002 |
Raychaudhuri B, Bonfield TL, Malur A, Hague K, Kavuru MS, Arroliga AC, Thomassen MJ. Circulating monocytes from patients with primary pulmonary hypertension are hyporesponsive. Clinical Immunology (Orlando, Fla.). 104: 191-8. PMID 12165280 DOI: 10.1006/Clim.2002.5253 |
0.482 |
|
| 2002 |
Wishah K, Malur A, Raychaudhuri B, Melton AL, Kavuru MS, Thomassen MJ. Nitric oxide blocks inflammatory cytokine secretion triggered by CD23 in monocytes from allergic, asthmatic patients and healthy controls. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 89: 78-82. PMID 12141726 DOI: 10.1016/S1081-1206(10)61915-1 |
0.416 |
|
| 2002 |
Raychaudhuri B, Malur A, Bonfield TL, Abraham S, Schilz RJ, Farver CF, Kavuru MS, Arroliga AC, Thomassen MJ. The prostacyclin analogue treprostinil blocks NFkappaB nuclear translocation in human alveolar macrophages. The Journal of Biological Chemistry. 277: 33344-8. PMID 12082102 DOI: 10.1074/Jbc.M203567200 |
0.5 |
|
| 2002 |
Barna BP, Dweik RA, Farver CF, Culver D, Yen-Lieberman B, Thomassen MJ. Nitric oxide attenuates beryllium-induced IFNγ responses in chronic beryllium disease: Evidence for mechanisms independent of IL-18 Clinical Immunology. 103: 169-175. PMID 12027422 DOI: 10.1006/Clim.2002.5211 |
0.32 |
|
| 2001 |
Mazzone P, Thomassen MJ, Kavuru M. Our new understanding of pulmonary alveolar proteinosis: what an internist needs to know. Cleveland Clinic Journal of Medicine. 68: 977-993. PMID 11765122 DOI: 10.3949/Ccjm.68.12.977 |
0.484 |
|
| 2001 |
Thomassen MJ, Kavuru MS. Human alveolar macrophages and monocytes as a source and target for nitric oxide. International Immunopharmacology. 1: 1479-1490. PMID 11515813 DOI: 10.1016/S1567-5769(01)00092-3 |
0.502 |
|
| 2001 |
Uetani K, Thomassen MJ, Erzurum SC. Nitric oxide synthase 2 through an autocrine loop via respiratory epithelial cell-derived mediator American Journal of Physiology - Lung Cellular and Molecular Physiology. 280. PMID 11350796 DOI: 10.1152/Ajplung.2001.280.6.L1179 |
0.411 |
|
| 2000 |
Farver CF, Raychaudhuri B, Malur A, Drazba J, Maurer J, Tubbs R, Mehta AC, Schilz R, Thomassen MJ. Increased alveolar macrophage nuclear factor-kappa B activation and macrophage inhibitory protein-1alpha levels in lung transplant patients. Transplantation. 70: 1599-603. PMID 11152221 DOI: 10.1097/00007890-200012150-00010 |
0.463 |
|
| 2000 |
Raychaudhuri B, Fisher CJ, Farver CF, Malur A, Drazba J, Kavuru MS, Thomassen MJ. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine. 12: 1348-55. PMID 10975994 DOI: 10.1006/Cyto.2000.0721 |
0.383 |
|
| 2000 |
Comhair SAA, Thomassen MJ, Erzurum SC. Differential induction of extracellular glutathione peroxidase and nitric oxide synthase 2 in airways of healthy individuals exposed to 100% O2 or cigarette smoke American Journal of Respiratory Cell and Molecular Biology. 23: 350-354. PMID 10970826 DOI: 10.1165/Ajrcmb.23.3.4076 |
0.339 |
|
| 2000 |
Guo FH, Comhair SA, Zheng S, Dweik RA, Eissa NT, Thomassen MJ, Calhoun W, Erzurum SC. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. Journal of Immunology (Baltimore, Md. : 1950). 164: 5970-80. PMID 10820280 DOI: 10.4049/Jimmunol.164.11.5970 |
0.308 |
|
| 2000 |
Wu W, Samoszuk MK, Comhair SA, Thomassen MJ, Farver CF, Dweik RA, Kavuru MS, Erzurum SC, Hazen SL. Eosinophils generate brominating oxidants in allergen-induced asthma. The Journal of Clinical Investigation. 105: 1455-63. PMID 10811853 DOI: 10.1172/Jci9702 |
0.351 |
|
| 2000 |
Thomassen MJ, Yi T, Raychaudhuri B, Malur A, Kavuru MS. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clinical Immunology. 95: 85-92. PMID 10779401 DOI: 10.1006/Clim.2000.4859 |
0.511 |
|
| 2000 |
Kavuru MS, Sullivan EJ, Piccin R, Thomassen MJ, Stoller JK. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. American Journal of Respiratory and Critical Care Medicine. 161: 1143-8. PMID 10764303 DOI: 10.1164/Ajrccm.161.4.9906044 |
0.52 |
|
| 1999 |
Thomassen MJ, Raychaudhuri B, Dweik RA, Farver C, Buhrow L, Malur A, Connors MJ, Drazba J, Hammel J, Erzurum SC, Kavuru MS. Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. The Journal of Allergy and Clinical Immunology. 104: 1174-82. PMID 10588998 DOI: 10.1016/S0091-6749(99)70010-2 |
0.313 |
|
| 1999 |
Raychaudhuri B, Dweik R, Connors MJ, Buhrow L, Malur A, Drazba J, Arroliga AC, Erzurum SC, Kavuru MS, Thomassen MJ. Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. American Journal of Respiratory Cell and Molecular Biology. 21: 311-6. PMID 10460748 DOI: 10.1165/Ajrcmb.21.3.3611 |
0.428 |
|
| 1999 |
Kavuru MS, Dweik RA, Thomassen MJ. Role of bronchoscopy in asthma research. Clinics in Chest Medicine. 20: 153-189. PMID 10205724 DOI: 10.1016/S0272-5231(05)70133-7 |
0.326 |
|
| 1999 |
Dinakar C, Malur A, Raychaudhuri B, Buhrow LT, Melton AL, Kavuru MS, Thomassen MJ. Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 82: 217-22. PMID 10071528 DOI: 10.1016/S1081-1206(10)62600-2 |
0.464 |
|
| 1998 |
Farver CF, Raychaudhuri B, Buhrow LT, Connors MJ, Thomassen MJ. CONSTITUTIVE NF-κB LEVELS IN HUMAN ALVEOLAR MACROPHAGES FROM NORMAL VOLUNTEERS Cytokine. 10: 868-871. PMID 9878123 DOI: 10.1006/Cyto.1998.0373 |
0.418 |
|
| 1998 |
Kaneko FT, Arroliga AC, Dweik RA, Comhair SA, Laskowski D, Oppedisano R, Thomassen MJ, Erzurum SC. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension American Journal of Respiratory and Critical Care Medicine. 158: 917-923. PMID 9731026 DOI: 10.1164/Ajrccm.158.3.9802066 |
0.367 |
|
| 1997 |
Thomassen MJ, Buhrow LT, Wiedemann HP. Perflubron decreases inflammatory cytokine production by human alveolar macrophages Critical Care Medicine. 25: 2045-2047. PMID 9403756 DOI: 10.1097/00003246-199712000-00023 |
0.486 |
|
| 1997 |
Dweik RA, Lewis M, Kavuru M, Buhrow L, Erzurum SC, Thomassen MJ. Inhaled corticosteroids and β-agonists inhibit oxidant production by bronchoalveolar lavage cells from normal volunteers in vivo Immunopharmacology. 37: 163-166. PMID 9403334 DOI: 10.1016/S0162-3109(97)00043-X |
0.352 |
|
| 1997 |
Thomassen MJ, Buhrow LT, Connors MJ, Kaneko FT, Erzurum SC, Kavuru MS. Nitric Oxide Inhibits Inflammatory Cytokine Production by Human Alveolar Macrophages American Journal of Respiratory Cell and Molecular Biology. 17: 279-283. PMID 9308913 DOI: 10.1165/Ajrcmb.17.3.2998M |
0.387 |
|
| 1996 |
Thomassen MJ, Divis LT, Fisher CJ. Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. Clinical Immunology and Immunopathology. 80: 321-4. PMID 8811054 DOI: 10.1006/Clin.1996.0130 |
0.376 |
|
| 1996 |
Thomassen MJ, Antal JM, Barna BP, Divis LT, Meeker DP, Wiedemann HP. Surfactant downregulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts. The American Journal of Physiology. 270: L159-63. PMID 8772539 DOI: 10.1152/Ajplung.1996.270.1.L159 |
0.451 |
|
| 1996 |
Barna BP, Thomassen MJ, Zhou P, Pettay J, Singh‐Burgess S, Deodhar SD. Activation of alveolar macrophage TNF and MCP‐1 expression in vivo by a synthetic peptide of C‐reactive protein Journal of Leukocyte Biology. 59: 397-402. PMID 8604018 DOI: 10.1002/Jlb.59.3.397 |
0.476 |
|
| 1996 |
Antal JM, Divis LT, Erzurum SC, Wiedemann HP, Thomassen MJ. Surfactant Suppresses NF-κB Activation in Human Monocytic Cells American Journal of Respiratory Cell and Molecular Biology. 14: 374-379. PMID 8600942 DOI: 10.1165/Ajrcmb.14.4.8600942 |
0.422 |
|
| 1995 |
Zhou P, Thomassen MJ, Pettay J, Deodhar SD, Barna BP. Human monocytes produce monocyte chemoattractant protein 1 (MCP-1) in response to a synthetic peptide derived from c-reactive protein Clinical Immunology and Immunopathology. 74: 84-88. PMID 7994930 DOI: 10.1006/Clin.1995.1012 |
0.322 |
|
| 1995 |
Thomassen MJ, Antal JM, Divis LT, Wiedemann HP. Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: a component of the synthetic surfactant Exosurf. Clinical Immunology and Immunopathology. 77: 201-5. PMID 7586728 DOI: 10.1006/Clin.1995.1144 |
0.464 |
|
| 1994 |
Barna BP, Thomassen MJ, Maier M, Medendorp SV, Tubbs RR, Chiang T, Zhou P, Yen-Lieberman B, Singh-Burgess S, Deodhar SD. Combination therapy with a synthetic peptide of C-reactive protein and interleukin 2: augmented survival and eradication of pulmonary metastases. Cancer Immunology, Immunotherapy : Cii. 38: 38-42. PMID 8299117 DOI: 10.1007/Bf01517168 |
0.314 |
|
| 1994 |
Thomassen MJ, Antal JM, Connors MJ, Meeker DP, Wiedemann HP. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. American Journal of Respiratory Cell and Molecular Biology. 10: 399-404. PMID 8136155 DOI: 10.1165/Ajrcmb.10.4.8136155 |
0.443 |
|
| 1994 |
Thomassen M, Antal J, Divis L, Meeker D, Wiedemann H. Pulmonary surfactant suppresses production of inflammatory mediators by human alveolar macrophages (AMs) and lung parenchymal cells Cytokine. 6: 550. DOI: 10.1016/1043-4666(94)90152-X |
0.523 |
|
| 1993 |
Thomassen MJ, Meeker DP, Deodhar SD, Wiedemann HP, Barna BP. Activation of human monocytes and alveolar macrophages by a synthetic peptide of C-reactive protein. Journal of Immunotherapy. 13: 1-6. PMID 8435427 DOI: 10.1097/00002371-199301000-00001 |
0.35 |
|
| 1993 |
Bukowski RM, Murthy S, Mclain D, Finke J, Andresen S, Tubbs R, Bauer L, Gibson V, Budd GT, Thomassen MJ. Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects. Journal of Immunotherapy. 13: 267-274. PMID 8334111 DOI: 10.1097/00002371-199305000-00006 |
0.451 |
|
| 1992 |
Thomassen MJ, Meeker DP, Antal JM, Connors MJ, Wiedemann HP. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. American Journal of Respiratory Cell and Molecular Biology. 7: 257-60. PMID 1520490 DOI: 10.1165/Ajrcmb/7.3.257 |
0.342 |
|
| 1991 |
Barna BP, Rogers LR, Thomassen MJ, Barnett GH, Estes ML. Monocyte tumoricidal activity and tumor necrosis factor production in patients with malignant brain tumors. Cancer Immunology, Immunotherapy : Cii. 33: 314-8. PMID 1868490 DOI: 10.1007/Bf01756596 |
0.344 |
|
| 1991 |
Maier MC, Melton AL, Thomassen MJ, Pettay J, Barna BP. 584 The effect of IL-2 and synthetic CRP peptide on TNF production by murine pulmonary macrophages The Journal of Allergy and Clinical Immunology. 87: 285. DOI: 10.1016/0091-6749(91)91866-R |
0.395 |
|
| 1990 |
Thomassen MJ, Barna BP, Wiedemann HP, Bukowski RM, Farmer M, Ahmad M. Immunologic studies of alveolar macrophages from patients with metastatic renal cell carcinoma. The American Review of Respiratory Disease. 141: 1256-1258. PMID 2339845 DOI: 10.1164/Ajrccm/141.5_Pt_1.1256 |
0.422 |
|
| 1990 |
Thomassen MJ, Barna BP, Farmer MO, Doershuk CF, Stern RC. Monocytes in cystic fibrosis: responsiveness to microbial stimuli. Pediatric Pulmonology. 8: 178-81. PMID 2161509 DOI: 10.1002/Ppul.1950080309 |
0.367 |
|
| 1988 |
Thomassen MJ, Barna BP, Wiedemann HP, Farmer M, Ahmad M. Human Alveolar Macrophage Function: Differences Between Smokers and Nonsmokers Journal of Leukocyte Biology. 44: 313-318. PMID 2846725 DOI: 10.1002/Jlb.44.5.313 |
0.429 |
|
| 1987 |
Tablan OC, Martone WJ, Doershuk CF, Stern RC, Thomassen MJ, Klinger JD, White JW, Carson LA, Jarvis WR. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest. 91: 527-32. PMID 3829745 DOI: 10.1378/Chest.91.4.527 |
0.304 |
|
| 1987 |
Thomassen MJ, Demko CA, Doershuk CF. Cystic fibrosis: a review of pulmonary infections and interventions. Pediatric Pulmonology. 3: 334-51. PMID 3313220 DOI: 10.1002/Ppul.1950030510 |
0.32 |
|
| 1987 |
Shryock TR, Sherman JM, Klinger JD, Thomassen MJ. Lack of development of phagocytic inhibitory activity in serum of cats immunized with Enterobacter cloacae lipopolysaccharide Current Microbiology. 14: 251-253. DOI: 10.1007/Bf01568131 |
0.325 |
|
| 1984 |
Sherman JM, Winnie G, Thomassen MJ, Abdul-Karim FW, Boat TF. Time course of hemosiderin production and clearance by human pulmonary macrophages. Chest. 86: 409-11. PMID 6468000 DOI: 10.1378/Chest.86.3.409 |
0.486 |
|
| 1984 |
Thomassen MJ, Klinger JD, Badger SJ, van Heeckeren DW, Stern RC. Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis. The Journal of Pediatrics. 104: 352-6. PMID 6423790 DOI: 10.1016/S0022-3476(84)81094-X |
0.317 |
|
| 1981 |
Konstan MW, Chen PW, Sherman JM, Thomassen MJ, Wood RE, Boat TF. Human lung lysozyme: sources and properties. The American Review of Respiratory Disease. 123: 120-4. PMID 26625489 DOI: 10.1164/Arrd.1981.123.1.120 |
0.401 |
|
| 1981 |
Sherman JM, Winnie GB, Boat TF, Thomassen MJ. 1724 PULMONARY HEMORRHAGE IN PREVIOUSLY WELL INFANTS: TIME COURSE OF HEMOSIDERIN PRODUCTION Pediatric Research. 15: 731-731. DOI: 10.1203/00006450-198104001-01743 |
0.311 |
|
| Show low-probability matches. |